Revista Espanola de Quimioterapia

Papers
(The H4-Index of Revista Espanola de Quimioterapia is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Recommendations for use of antigenic tests in the diagnosis of acute SARS-CoV-2 infection in the second pandemic wave: attitude in different clinical settings46
New variants of SARS-CoV-246
Pharmacological treatment of COVID-19: an opinion paper41
Insights for COVID-19 in 202336
Temporary hospitals in times of the COVID pandemic. An example and a practical view29
Monkeypox in humans: a new outbreak29
Secondary infections in mechanically ventilated patients with COVID-19: An overlooked matter?29
Nirmatrelvir plus ritonavir (Paxlovid) a potent SARS-CoV-2 3CLpro protease inhibitor combination28
Utility of lateral flow tests in SARS-CoV-2 infection monitorization23
Remdesivir, the antiviral hope against SARS-CoV-220
Real-life use of remdesivir in hospitalized patients with COVID-1919
COVID-19: Impact on prescribing and antimicrobial resistance17
The first 100 cases of COVID-19 in a Hospital in Madrid with a 2-month follow-up17
Aspiration pneumonia15
0.080996990203857